Advantage Austria Show navigation
We think you are in the USAGo to this country pageChange country

Market share of more than 40% in Taiwan

Greiner Bio-One, Austria was the first company worldwide to develop evacuated blood-collection tubes made from PET with safety caps - the VACUETTE® Blood Collection System. This innovation has become the standard in the diagnostic industry for all countries around the globe.

Taiwan has a strong and diversified local biotech industry. It is a price-sensitive and very competitive market. For more than 25 years, Greiner Bio-One has supplied the diagnostic & pharmaceutical industry in Taiwan with innovative products.

Over the past years the VACUETTE® Blood Collection System has reached a market share of more than 40% in Taiwan In spite of fierce competition from local manufacturers and other suppliers in the region. This great success proves that quality and excellent service are highly appreciated by customers. Turnover in 2013 will reach approx. 2.4 million Euros.

At the end of 2008 Greiner Bio-One opened a new production plant in Thailand in order to cater to the steadily growing demand of all major markets in Asia. The design of the factory was based on the latest production technology. Efficiency and quality management correspond to European standards.
print
©©ADVANTAGE AUSTRIA